Coronavirus: Swiss federal government secures supply of vaccines for 2023
Bern, 11.3.2022 - At its 11 March 2022 meeting, the Federal Council approved the procurement plan for COVID-19 vaccines for 2023. The main goal is to ensure the supply for members of the public under all pandemic scenarios. Seven million doses of Pfizer/BioNTech and seven million doses of Moderna vaccine will be procured for 2023, with options for an additional seven million doses of each. The Federal Council has also decided to provide the Coalition for Epidemic Preparedness Innovation (CEPI) with a further ten million francs in funding. The Federal Council is applying to Parliament for a supplementary credit for the procurement of COVID-19 drugs.